Focus on Immune-Mediated Inflammatory Diseases
Recently, I decided to capitalize on my scientific work to create a translational structure of excellence bringing together researchers, clinicians, industry actors and state-of-the-art technological platforms within a patient-focused health care dedicated to Immune-Mediated Inflammatory Diseases (IMID).
The European Institute of IMID (E3I) and the FHU Curing and Preventing IMID (CURE) that bring together 400 physicians and reseachers within the Grand-Est region in France will be launched at the end of 2020.
Laurent Peyrin-Biroulet - Numéro un au monde dans le traitement et la recherche des MICI
29 décembre 2019